BRPI0413394A - formulação de lantánio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantánio, processo para preparar uma formulação em tablete de um composto de lantánio - Google Patents
formulação de lantánio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantánio, processo para preparar uma formulação em tablete de um composto de lantánioInfo
- Publication number
- BRPI0413394A BRPI0413394A BRPI0413394-3A BRPI0413394A BRPI0413394A BR PI0413394 A BRPI0413394 A BR PI0413394A BR PI0413394 A BRPI0413394 A BR PI0413394A BR PI0413394 A BRPI0413394 A BR PI0413394A
- Authority
- BR
- Brazil
- Prior art keywords
- formulation
- tablet
- lanthanum
- compound
- powder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Abstract
"FORMULAçãO DE LANTáNIO MASTIGáVEL EM TABLETE, FORMULAçãO FARMACêUTICA EM TABLETE OU EM Pó, MéTODO PARA TRATAR HIPERFOSFATEMIA, USO DE UMA QUANTIDADE TERAPEUTICAMENTE EFETIVA DE UMA FORMULAçãO DE UM COMPOSTO DE LANTáNIO, PROCESSO PARA PREPARAR UMA FORMULAçãO EM TABLETE DE UM COMPOSTO DE LANTáNIO". Esta invenção refere-se a uma formulação de lantânio mastigável compreendendo uma quantidade farmaceuticamente efetiva de um composto de lantânio; e pelo menos um excipiente farmaceuticamente aceitável mastigável. Este invenção também refere-se a uma formulação farmacêutica em um tablete ou em pó, compreendendo uma quantidade farmaceuticamente efetiva de um composto de lantânio produzido através de um processo que compreende as etapas de: a) misturar o composto de lantânio em pó e pelo menos um excipiente farmaceuticamente aceitável em um misturador para formar uma mistura; ou b) misturar o composto de lantânio em pó e excipientes, comprimir a combinação resultante em um material espaçado, ou compactar com um rolete a combinação resultante dentro de um material em corda, e triturar o material preparado em uma mistura livre de fluxo; e c) comprimir a mistura resultante em um tablete ou preencher a mistura resultante em um recipiente apropriado.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49756003P | 2003-08-26 | 2003-08-26 | |
US51707803P | 2003-11-05 | 2003-11-05 | |
PCT/CA2004/001563 WO2005018651A1 (en) | 2003-08-26 | 2004-08-26 | Pharmaceutical formulation comprising lanthanum compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0413394A true BRPI0413394A (pt) | 2006-10-17 |
BRPI0413394A8 BRPI0413394A8 (pt) | 2016-03-08 |
Family
ID=34221462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0413394A BRPI0413394A8 (pt) | 2003-08-26 | 2004-08-26 | Formulação de lantânio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantânio, processo para preparar uma formulação em tablete de um composto de lantânio |
Country Status (29)
Country | Link |
---|---|
US (2) | US7465465B2 (pt) |
EP (4) | EP2172205B1 (pt) |
JP (2) | JP4896719B2 (pt) |
KR (1) | KR100830764B1 (pt) |
CN (1) | CN1871018B (pt) |
AT (2) | ATE460169T1 (pt) |
AU (2) | AU2004266050B2 (pt) |
BR (1) | BRPI0413394A8 (pt) |
CA (1) | CA2536959C (pt) |
CY (2) | CY1110241T1 (pt) |
CZ (1) | CZ17621U1 (pt) |
DE (2) | DE602004025950D1 (pt) |
DK (5) | DK1660104T3 (pt) |
EA (2) | EA200970709A1 (pt) |
ES (4) | ES2532389T3 (pt) |
FI (1) | FI7568U1 (pt) |
HK (1) | HK1084338A1 (pt) |
HU (2) | HUE029382T2 (pt) |
IL (2) | IL173755A0 (pt) |
IS (1) | IS2893B (pt) |
MX (1) | MXPA06002257A (pt) |
NO (1) | NO342559B1 (pt) |
NZ (1) | NZ545633A (pt) |
PL (4) | PL2792363T3 (pt) |
PT (4) | PT2792363T (pt) |
SG (1) | SG145765A1 (pt) |
SI (4) | SI1660104T1 (pt) |
WO (1) | WO2005018651A1 (pt) |
ZA (1) | ZA200602213B (pt) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
GB0015745D0 (en) * | 2000-06-27 | 2000-08-16 | Shire Holdings Ag | Treatment of bone diseases |
DE60239329D1 (de) * | 2001-04-23 | 2011-04-14 | Shire Int Licensing Bv | Verwendung von lanthankarbonat zur prävention von nierensteinleiden |
US20060083791A1 (en) | 2002-05-24 | 2006-04-20 | Moerck Rudi E | Rare earth metal compounds methods of making, and methods of using the same |
US20040161474A1 (en) * | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
US7381428B2 (en) * | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
JP4896719B2 (ja) | 2003-08-26 | 2012-03-14 | シャイアー ホールディングス アーゲー | ランタン化合物を含む医薬製剤 |
JP4869229B2 (ja) * | 2004-07-27 | 2012-02-08 | シア ファーマシューティカルズ,インク. | 水酸化炭酸ランタンを用いた高リン血症を治療するための医薬組成物 |
US7700608B2 (en) * | 2004-08-04 | 2010-04-20 | Shire Holdings Ag | Quinazoline derivatives and their use in the treatment of thrombocythemia |
CA2583548A1 (en) * | 2004-10-15 | 2006-04-27 | Altairnano, Inc. | Phosphate binder with reduced pill burden |
ITME20040015A1 (it) | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
EP1698233A1 (en) * | 2005-03-01 | 2006-09-06 | Bayer HealthCare AG | Reduction of digestibility of phosphorus in animal nutrition |
AU2006279364A1 (en) * | 2005-08-17 | 2007-02-22 | Altairnano, Inc. | Hyperphosphatemia in domestic animals: compositions and methods of treatment |
US20080058250A1 (en) * | 2005-08-17 | 2008-03-06 | Allison Wren | Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
US20070104799A1 (en) * | 2005-11-09 | 2007-05-10 | Shire International Licensing B.V. | Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
CN100398112C (zh) * | 2006-03-24 | 2008-07-02 | 辽宁诺康生物制药有限责任公司 | 一种治疗血磷酸盐过多症的药物及其制备方法 |
GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
CA2694516A1 (en) * | 2007-07-31 | 2009-02-05 | Cargill, Incorporated | Direct compressible dextrose |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
TWI592159B (zh) | 2007-11-16 | 2017-07-21 | 威佛(國際)股份有限公司 | 藥學組成物 |
US8974824B2 (en) * | 2008-03-26 | 2015-03-10 | Mylan Laboratories Ltd. | Lanthanum composition |
US8962036B2 (en) | 2009-01-21 | 2015-02-24 | Mylan Pharmaceuticals Inc. | Disintegrable formulations of lanthanum carbonate |
WO2010106557A2 (en) * | 2009-03-20 | 2010-09-23 | Panacea Biotec Limited | Stable pharmaceutical formulations comprising anhydrous lanthanum carbonate and process for preparation thereof |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
WO2011051968A2 (en) * | 2009-10-26 | 2011-05-05 | Alkem Laboratories Ltd. | Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
ES2871021T3 (es) | 2010-05-12 | 2021-10-28 | Spectrum Pharmaceuticals Inc | Hidróxido de carbonato de lantano, oxicarbonato de lantano y procedimientos de fabricación y uso |
EP2441436A1 (de) | 2010-10-13 | 2012-04-18 | Fresenius Medical Care Deutschland GmbH | Phosphatbinderformulierung zur einfachen Einnahme |
US8697132B2 (en) * | 2010-12-01 | 2014-04-15 | Shire Llc | Capsule and powder formulations containing lanthanum compounds |
US8263119B2 (en) * | 2010-12-01 | 2012-09-11 | Shire Llc | Capsule formulations containing lanthanum compounds |
CN103127041A (zh) * | 2012-02-23 | 2013-06-05 | 南京卡文迪许生物工程技术有限公司 | 含有醋酸镧的药物组合物及其制备方法和用途 |
DE102012209411A1 (de) | 2012-06-04 | 2013-12-05 | Fim Biotech Gmbh | Mineralische Verbindung zur Reduzierung von anorganischen Phosphaten, insbesondere im Rahmen einer Nierenersatztherapie |
CN104473963B (zh) * | 2014-12-24 | 2017-10-10 | 厦门科明达科技有限公司 | 稀土化学药碳酸镧咀嚼片的制备方法 |
JP2016147827A (ja) * | 2015-02-12 | 2016-08-18 | 株式会社三和化学研究所 | 炭酸ランタン水和物を含有する医薬製剤 |
US10058569B2 (en) | 2015-06-24 | 2018-08-28 | Lupin Limited | Lanthanum carbonate compositions |
JP6093829B1 (ja) * | 2015-10-02 | 2017-03-08 | バイエル薬品株式会社 | ランタン化合物を含む医薬組成物 |
JP6623753B2 (ja) * | 2015-12-28 | 2019-12-25 | ニプロ株式会社 | 炭酸ランタンを含む口腔内崩壊錠 |
CN107213126B (zh) * | 2017-05-17 | 2020-06-23 | 西安棣加生物科技有限公司 | 一种3d打印技术制备治疗高磷血症的口腔速崩片的方法 |
CN108969497A (zh) * | 2018-10-12 | 2018-12-11 | 沈阳华泰药物研究有限公司 | 一种碳酸镧片剂组合物及其制备方法 |
EP4061340A4 (en) * | 2019-11-21 | 2023-08-09 | Santa Farma Ilaç Sanayi A.S. | ORAL SOLID PHARMACEUTICAL COMPOSITIONS WITH LANTANHANE CARBONATE OCTAHYDRATE |
CN113244179B (zh) * | 2021-05-21 | 2023-01-13 | 浙江仟源海力生制药有限公司 | 一种稳定性好的碳酸镧片剂及其制备方法和其应用 |
US20230123099A1 (en) * | 2021-10-15 | 2023-04-20 | Fertin Pharma A/S | Dextrose tablets with improved mouthfeel |
CN115813867A (zh) * | 2022-12-01 | 2023-03-21 | 山东齐都药业有限公司 | 碳酸镧冻干片及其制备方法 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54155675A (en) * | 1978-05-30 | 1979-12-07 | Matsushita Electronics Corp | Small-sized fluorescent lamp |
JPH06705B2 (ja) | 1985-12-19 | 1994-01-05 | 旭化成工業株式会社 | リン酸イオンの固定化剤 |
US4822594A (en) * | 1987-01-27 | 1989-04-18 | Gibby Wendell A | Contrast enhancing agents for magnetic resonance images |
JPS6485088A (en) | 1987-06-19 | 1989-03-30 | Takeda Chemical Industries Ltd | Production of 2-keto-l-gulonic acid |
US4877735A (en) | 1987-06-19 | 1989-10-31 | Takeda Chemical Industries, Ltd. | Process for producing 2-keto-L-gulonic acid |
DE3724188C2 (de) | 1987-07-17 | 1995-05-18 | Heinz Dr Gries | Metallhaltige Oligosaccharid-Polysulfate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel |
DK0620728T3 (da) * | 1992-01-13 | 1997-07-07 | Pfizer | Fremstilling af tabletter med forøget styrke |
NZ285766A (en) | 1994-05-20 | 1997-09-22 | Janssen Pharmaceutica Nv | Anthelmintic compositions comprising flubendazole and brewers yeast |
CA2128199C (en) * | 1994-07-15 | 1997-02-04 | Bernard Charles Sherman | Stable solid pharmaceutical compositions containing enalapril maleate |
JP3591886B2 (ja) | 1994-09-05 | 2004-11-24 | シーシーアイ株式会社 | 希土類元素集積微生物 |
GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
TW506836B (en) * | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
US6074672A (en) | 1996-06-28 | 2000-06-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Powdered cosmetic compositions containing silicone elastomers |
GB9720061D0 (en) * | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
US20010014352A1 (en) * | 1998-05-27 | 2001-08-16 | Udit Batra | Compressed tablet formulation |
GB9816899D0 (en) * | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
JP2000173537A (ja) * | 1998-09-29 | 2000-06-23 | Toshiba Lighting & Technology Corp | 低圧水銀蒸気放電灯および照明装置 |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6160016A (en) * | 1999-12-22 | 2000-12-12 | Wisconsin Alumni Research Foundation | Phosphorus binder |
GB0008392D0 (en) * | 2000-04-05 | 2000-05-24 | Unilever Plc | Process for the production of a deodorant or antiperspirant product |
GB0015745D0 (en) * | 2000-06-27 | 2000-08-16 | Shire Holdings Ag | Treatment of bone diseases |
US20020057059A1 (en) * | 2000-07-28 | 2002-05-16 | Kazuhisa Ogishi | Fluorescent lamp, self-ballasted fluorescent lamp and lighting apparatus |
JP2002047210A (ja) | 2000-08-04 | 2002-02-12 | Nihon Medi Physics Co Ltd | 尿路結石防止用組成物 |
JP4612183B2 (ja) | 2000-12-27 | 2011-01-12 | 株式会社ヤクルト本社 | 皮膚外用組成物及びその製造方法 |
US7090875B2 (en) * | 2000-12-19 | 2006-08-15 | Kabushiki Kaisha Yakult Honsha | External skin preparations and process for producing the same |
JP4612180B2 (ja) | 2000-12-19 | 2011-01-12 | 株式会社ヤクルト本社 | 皮膚外用剤 |
US20020122823A1 (en) | 2000-12-29 | 2002-09-05 | Bunick Frank J. | Soft tablet containing dextrose monohydrate |
WO2002058699A1 (en) * | 2001-01-25 | 2002-08-01 | Bristol-Myers Squibb Company | Pharmaceutical forms of epothilones for oral administration |
DE60239329D1 (de) * | 2001-04-23 | 2011-04-14 | Shire Int Licensing Bv | Verwendung von lanthankarbonat zur prävention von nierensteinleiden |
GB0201607D0 (en) * | 2002-01-24 | 2002-03-13 | Gamlen Michael J D | Formulation for the administration of medicinal substances |
ATE425744T1 (de) * | 2002-04-29 | 2009-04-15 | Supernus Pharmaceuticals Inc | Pharmazeutische formulierungen mit verbesserter bioverfugbarkeit |
WO2003094933A2 (en) | 2002-05-08 | 2003-11-20 | Shire Holding Ag | Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
US7220406B2 (en) * | 2002-10-22 | 2007-05-22 | Genzyme Corporation | Method for promoting bone formation |
JP4896719B2 (ja) | 2003-08-26 | 2012-03-14 | シャイアー ホールディングス アーゲー | ランタン化合物を含む医薬製剤 |
US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
US7608674B2 (en) | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7335795B2 (en) * | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US7385012B2 (en) * | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
US7449605B2 (en) * | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
US7545784B2 (en) * | 2004-02-11 | 2009-06-09 | Yahoo! Inc. | System and method for wireless communication between previously known and unknown users |
US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US8282960B2 (en) * | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
KR101228233B1 (ko) | 2004-03-30 | 2013-01-31 | 리립사, 인크. | 이온 결합 중합체 및 이의 용도 |
US7854924B2 (en) * | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
JP4869229B2 (ja) * | 2004-07-27 | 2012-02-08 | シア ファーマシューティカルズ,インク. | 水酸化炭酸ランタンを用いた高リン血症を治療するための医薬組成物 |
AR061727A1 (es) * | 2006-06-30 | 2008-09-17 | Schering Corp | Sintesis de dietil [[ 5- ( 3-fluorofenil) -piridin -2il] metil] fosfonato |
US8974824B2 (en) | 2008-03-26 | 2015-03-10 | Mylan Laboratories Ltd. | Lanthanum composition |
-
2004
- 2004-08-26 JP JP2006524189A patent/JP4896719B2/ja active Active
- 2004-08-26 PL PL14167982T patent/PL2792363T3/pl unknown
- 2004-08-26 ES ES09172030.0T patent/ES2532389T3/es active Active
- 2004-08-26 CN CN2004800315788A patent/CN1871018B/zh active Active
- 2004-08-26 EA EA200970709A patent/EA200970709A1/ru unknown
- 2004-08-26 DE DE602004025950T patent/DE602004025950D1/de active Active
- 2004-08-26 CZ CZ200718525U patent/CZ17621U1/cs not_active IP Right Cessation
- 2004-08-26 DK DK04761727.9T patent/DK1660104T3/da active
- 2004-08-26 MX MXPA06002257A patent/MXPA06002257A/es active IP Right Grant
- 2004-08-26 PL PL10151270T patent/PL2172205T3/pl unknown
- 2004-08-26 EP EP20100151270 patent/EP2172205B1/en active Active
- 2004-08-26 AU AU2004266050A patent/AU2004266050B2/en active Active
- 2004-08-26 PL PL04761727T patent/PL1660104T3/pl unknown
- 2004-08-26 SI SI200431437T patent/SI1660104T1/sl unknown
- 2004-08-26 DK DK10151270T patent/DK2172205T3/da active
- 2004-08-26 PT PT141679829T patent/PT2792363T/pt unknown
- 2004-08-26 ES ES14167982.9T patent/ES2592803T3/es active Active
- 2004-08-26 EP EP20090172030 patent/EP2133084B1/en active Active
- 2004-08-26 HU HUE14167982A patent/HUE029382T2/en unknown
- 2004-08-26 PT PT04761727T patent/PT1660104E/pt unknown
- 2004-08-26 CA CA2536959A patent/CA2536959C/en active Active
- 2004-08-26 DE DE202004021169U patent/DE202004021169U1/de not_active Expired - Lifetime
- 2004-08-26 SG SG200806201-0A patent/SG145765A1/en unknown
- 2004-08-26 SI SI200432171T patent/SI2172205T1/sl unknown
- 2004-08-26 DK DK14167982.9T patent/DK2792363T3/da active
- 2004-08-26 PL PL09172030T patent/PL2133084T3/pl unknown
- 2004-08-26 WO PCT/CA2004/001563 patent/WO2005018651A1/en active Application Filing
- 2004-08-26 AT AT04761727T patent/ATE460169T1/de active
- 2004-08-26 SI SI200432228T patent/SI2133084T1/sl unknown
- 2004-08-26 HU HUE09172030A patent/HUE024906T2/en unknown
- 2004-08-26 DK DK09172030T patent/DK2133084T3/en active
- 2004-08-26 NZ NZ545633A patent/NZ545633A/en unknown
- 2004-08-26 EP EP04761727A patent/EP1660104B1/en active Active
- 2004-08-26 EA EA200600479A patent/EA012798B1/ru not_active IP Right Cessation
- 2004-08-26 BR BRPI0413394A patent/BRPI0413394A8/pt not_active Application Discontinuation
- 2004-08-26 KR KR1020067003792A patent/KR100830764B1/ko active IP Right Grant
- 2004-08-26 PT PT91720300T patent/PT2133084E/pt unknown
- 2004-08-26 PT PT10151270T patent/PT2172205E/pt unknown
- 2004-08-26 EP EP14167982.9A patent/EP2792363B1/en not_active Revoked
- 2004-08-26 ES ES04761727T patent/ES2343354T3/es active Active
- 2004-08-26 US US10/926,330 patent/US7465465B2/en active Active
- 2004-08-26 ES ES10151270.5T patent/ES2478258T3/es active Active
- 2004-08-26 SI SI200432346A patent/SI2792363T1/sl unknown
-
2006
- 2006-02-15 IL IL173755A patent/IL173755A0/en not_active IP Right Cessation
- 2006-03-15 IS IS8353A patent/IS2893B/is unknown
- 2006-03-16 ZA ZA200602213A patent/ZA200602213B/xx unknown
- 2006-03-24 NO NO20061347A patent/NO342559B1/no unknown
- 2006-06-12 HK HK06106716.4A patent/HK1084338A1/xx unknown
- 2006-09-22 FI FI20060387U patent/FI7568U1/fi not_active IP Right Cessation
- 2006-09-26 DK DK200600252U patent/DK200600252U4/da not_active IP Right Cessation
- 2006-10-19 AT AT0075706U patent/AT9809U1/de not_active IP Right Cessation
-
2008
- 2008-09-24 US US12/237,381 patent/US20090017133A1/en not_active Abandoned
-
2009
- 2009-06-18 AU AU2009202429A patent/AU2009202429B2/en active Active
-
2010
- 2010-06-04 CY CY101100501T patent/CY1110241T1/el unknown
- 2010-07-30 JP JP2010171525A patent/JP2010248247A/ja active Pending
-
2014
- 2014-10-28 IL IL235371A patent/IL235371B/en active IP Right Grant
-
2016
- 2016-09-22 CY CY20161100942T patent/CY1118211T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0413394A (pt) | formulação de lantánio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantánio, processo para preparar uma formulação em tablete de um composto de lantánio | |
CL2010001275A1 (es) | Metodo para producir un producto intermedio compactado de bibw 2992 ma2 que comprende una etapa de compactacion por rodillos de bibw 2992 ma2 u opcionalmente en una premezcla con 0-1,0% de lubricante en un mezclador de caida libre o de volteo y una etapa de tamizado; producto intermedio compactado; comprimido. | |
HRP20160988T1 (hr) | Farmaceutski sastavi s dvostrukim djelovanjem na temelju superstruktura od antagonista/blokatora receptora angiotenzina (arb) i neutralnih inhibitora endopeptidaze (nep) | |
DE60104399D1 (de) | Pulverformulierung zur inhalation | |
PE20011227A1 (es) | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros | |
WO1994014490A1 (de) | Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel | |
EA200900451A1 (ru) | Способ получения композиции эстрадиола с медленным высвобождением ( варианты ), микросферы эстрадиола и холестерина и способ для одновременной контрацепции и гормонозамещения | |
AU7750894A (en) | Baking improver compositions | |
ZA200203439B (en) | Novel tropical oestroprogestational compositions with systemic effect. | |
WO2002013793A3 (en) | Method of making tablets and tablet compositions produced therefrom | |
ECSP088403A (es) | Formulacion farmaceutica de absorción oral y su método de administracion | |
MXPA01012882A (es) | Composiciones y metodos que comprenden gluconato de morfina. | |
GB0323684D0 (en) | Improvements in or relating to organic compounds | |
ITMI20071971A1 (it) | Composizione farmaceutica per la somministrazione sublinguale di progesterone, e metodo per la sua preparazione | |
EP1420827B8 (en) | 5-cnac as oral delivery agent for parathyroid hormone fragments | |
MY137846A (en) | Processes for the preparation of oral dosage formulations of modafinil | |
DE69924304D1 (de) | N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin | |
WO2007120838A3 (en) | Rapidly disintegrating solid oral dosage form of liquid dispersions | |
ES2171110A1 (es) | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. | |
AR028745A1 (es) | Mezcla de silicasoles y el metodo para prepararla | |
CY1117082T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει ενωσεις λανθανιου | |
BR0318167A (pt) | formulação de liberação controlada contendo um material hidrofóbico como o agente de liberação controlada | |
AR060039A1 (es) | Formulaciones novedosas | |
ATE350031T1 (de) | Synergistische leberschützende zusammensetzung und verfahren dazu | |
BRPI0418769A (pt) | composição farmacêutica compreendendo cefixima, processo para a preparação de uma forma de dosagem oral sólida compreendendo de partìculas de cefixima, método para conseguir bio-equivalência entre a forma de dosagem oral e uma suspensão e comprimido mastigável compreendendo cefixima |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: SHIRE BIOPHARMACEUTICALS HOLDINGS IRELAND LIMITED |
|
B25G | Requested change of headquarter approved |
Owner name: SHIRE BIOPHARMACEUTICALS HOLDINGS IRELAND LIMITED |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |